A 64-year-old man with chronic lymphocytic leukaemia on B-cell-depleting therapy is concerned about COVID-19. According to NACI and Canadian guidance,...

Question

A 64-year-old man with chronic lymphocytic leukaemia on B-cell-depleting therapy is concerned about COVID-19. According to NACI and Canadian guidance, which statement best reflects vaccination recommendations for adults who are moderately to severely immunocompromised?

Accepted Answer

They should receive an enhanced primary series and recommended booster doses

Answer

They should avoid COVID-19 vaccines due to theoretical safety concerns

Answer

They should receive the standard two-dose primary series only

Answer

They should delay all vaccines until 6 months after chemotherapy

Answer

They should receive live attenuated COVID-19 vaccines preferentially

ca-mccqe1 MCQ (SBA): COVID-19 vaccination in immunocompromised adult

A 64-year-old man with chronic lymphocytic leukaemia on B-cell-depleting therapy is concerned about COVID-19. According to NACI and Canadian guidance, which statement best reflects vaccination recommendations for adults who are moderately to severely immunocompromised?